Nuvation Bio Inc (NUVB)

Date: O: H: L: C: Vol:

Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	61.93%31.69	83.23	41.87	13.12	4.83
	4.25%82.72	79.35	83.92	66.21	65.85
Selling, General, and Administrative	11.18%42.59	38.31	40.33	37.36	38.48
Research and Development	12.51%30.66	35.05	34.30	28.85	27.36
Depreciation and Amortization	0.54	0.54	0.54	0.53	0.36
Operating Income/Loss	1,415%-51.04	3.88	-34.04	-56.43	-63.59
Nonoperating Income/Loss	878.63%-11.80	1.52	-2.56	0.64	4.58
Income/Loss From Continuing Operations Before Tax	1,264%-62.84	5.40	-36.59	-55.79	-59.01
Income Tax Expense/Benefit	-	-	-	-	-
	1,264%-62.84	5.40	-36.59	-55.79	-59.01
Attributable To Parent	1,264%-62.84	5.40	-36.59	-55.79	-59.01
Basic Average Shares	0.41%0.35	0.35	0.00	0.34	0.34
Diluted Average Shares	7.62%0.35	0.38	0.00	0.34	0.34
Basic Earnings Per Share	1,000.00%-0.18	0.02	-0.11	-0.16	-0.17
Diluted Earnings Per Share	1,900%-0.18	0.01	-0.11	-0.16	-0.17